Medicine and Dentistry
Bacterial Infection
90%
Disease
71%
Observational Study
62%
Virus Infection
46%
Triage
40%
Adeno Associated Virus 2
40%
COVID-19 Vaccine
40%
Cohort Analysis
40%
Antibiotics
36%
Biological Marker
35%
Infection
34%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
Acute Hepatitis
23%
Antibiotic Therapy
22%
Diagnosis
21%
Protocol Compliance
20%
Writing
20%
Informed Consent
20%
Sweat Test
20%
Independent Reviewer
20%
Physical Development
20%
Seasonal Variation
20%
Kolmogorov Smirnov Test
20%
Screening
20%
Newborn Screening
20%
Pathogen
20%
Cystic Fibrosis
20%
Emergency Care
20%
Antiinfective Agent
20%
Enzyme Linked Immunosorbent Assay
16%
Booster Dose
16%
COVID-19
15%
Immunoreactive Trypsinogen
14%
Diagnostic Test
13%
Partial Least Squares Regression
13%
Bacterial Pneumonia
12%
Human Herpesvirus 6
10%
Patient Assessment
10%
Oxygen Therapy
10%
Patient Care
10%
Comorbidity
10%
Feature Extraction
10%
Human Leukocyte Antigen
10%
Proteomics
10%
COVID-19 Vaccination
10%
Prospective Cohort Study
9%
Neonates
8%
T Cell
6%
Immunity
6%
Human Adenovirus C
6%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Infection
100%
COVID-19 Vaccine
60%
Cohort Study
60%
Disease
51%
SARS Coronavirus
50%
Virus Infection
46%
Biological Marker
45%
Observational Study
42%
Antibiotics
36%
Infection
34%
Antibacterial Therapy
20%
Adeno Associated Virus 2
20%
Neurologic Disease
20%
Comorbidity
20%
Infectious Agent
20%
Antiinfective Agent
20%
Enzyme-Linked Immunosorbent Assay
16%
Bacterial Pneumonia
12%
Prospective Cohort Study
11%
Bronchiolitis
10%
Leukocyte Antigen
10%
Human Adenovirus C
6%
Disease Predisposition
6%
Syndrome
5%
Penicillin Derivative
5%
Respiratory Virus
5%
Immunology and Microbiology
Adeno Associated Virus 2
40%
Blood Plasma
20%
Infectious Agent
20%
Physical Development
20%
Glycosylation
20%
Seroprevalence
20%
Human Leukocyte Antigen
10%
Immunology
10%
Human Herpesvirus 6
10%
Immunity
6%
T Cell
6%
Protein Expression
6%
Gene Expression
6%
Protein Processing
6%
Human Adenovirus C
6%
Virus Nucleocapsid
5%
COVID-19
5%
Adolescence
5%
